Stephenson Harwood LLP has advised AM-Pharma on the deal.AM-Pharma signed a €245 million exclusive license agreement deal with Kyowa Kirin, for the development and commercialisation of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Giulia Di Palma
…
This content is for Standard 1 Year members only. LoginJoin Now